AMKYDRI
Live / Allowed — Notice of allowance issued (as of 02 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99031079
- Mark type
- Stylized text
- Filed
- 06 Feb 2025
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Sept 2025 — ASSIGNED TO EXAMINER
- 04 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 06 Feb 2025 — NEW APPLICATION ENTERED